Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

10/08/2018 07:00

Aug 10 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               25.49               22.51            97.00    
                   (+13.2 pct)         (+11.6 pct)      (+3.8 pct)  
  Operating            3.50                2.38             9.70    
                   (+47.3 pct)         (+77.6 pct)      (-16.7 pct) 
  Recurring            4.81                2.93             9.60    
                   (+64.1 pct)                          (-18.1 pct) 
  Net                  3.57                2.01             7.00    
                   (+77.8 pct)                          (+7.8 pct)  
  EPS              217.41 yen          122.27 yen       426.75 yen  
  EPS Diluted      201.12 yen          113.06 yen                   
  Ann Div                               95.00 yen        95.00 yen  
  -Q2 div                               47.50 yen        47.50 yen  
  -Q4 div                               47.50 yen        47.50 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T